Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	phorbol ester receptor activity	UNC13B UNC13C	4.88e-05	2	140	2	GO:0001565
GeneOntologyMolecularFunction	non-kinase phorbol ester receptor activity	UNC13B UNC13C	4.88e-05	2	140	2	GO:0001566
GeneOntologyMolecularFunction	calcium ion binding	UNC13B NECAB2 PCDHGA7 SPTA1 ITSN1 PPP2R3B CASQ1 DYSF TENM2 RYR1 PPP2R3A CELSR1 GUCA1A USP32 ANXA10 UNC13C	7.35e-05	749	140	16	GO:0005509
GeneOntologyMolecularFunction	phosphatidylethanolamine binding	MAP1LC3A GABARAPL1 MAP1LC3C	3.01e-04	19	140	3	GO:0008429
GeneOntologyMolecularFunction	threonine-type peptidase activity	PSMB5 GGT2P GGT3P	3.52e-04	20	140	3	GO:0070003
GeneOntologyMolecularFunction	calcium- and calmodulin-responsive adenylate cyclase activity	ADCY3 ADCY8	4.81e-04	5	140	2	GO:0008294
GeneOntologyMolecularFunction	peptidyltransferase activity	GGT2P GGT3P	7.19e-04	6	140	2	GO:0000048
GeneOntologyMolecularFunction	leukotriene-C(4) hydrolase	GGT2P GGT3P	7.19e-04	6	140	2	GO:0002951
GeneOntologyMolecularFunction	histone H3K9me2/H3K9me3 demethylase activity	KDM4E KDM4B	7.19e-04	6	140	2	GO:0140684
GeneOntologyMolecularFunction	protein serine kinase activity	PAK4 WNK1 MAP3K6 CIITA MARK4 CHEK2 MASTL PAK2 PRKCA	1.07e-03	363	140	9	GO:0106310
GeneOntologyMolecularFunction	protein kinase activity	PAK4 WNK1 MAP3K6 TXK IGF1R CIITA MARK4 CHEK2 MASTL PAK2 PRKCA ROS1	1.08e-03	600	140	12	GO:0004672
GeneOntologyCellularComponent	cone photoreceptor outer segment	IFT140 GUCA1A PRKCA	4.57e-05	11	139	3	GO:0120199
GeneOntologyCellularComponent	calyx of Held	UNC13B ITSN1 PRKCA UNC13C	9.35e-05	36	139	4	GO:0044305
GeneOntologyCellularComponent	PML body	EIF3E TENM2 UBN1 CIITA ZNF451 CHEK2	1.90e-04	125	139	6	GO:0016605
GeneOntologyCellularComponent	terminal cisterna	CASQ1 RYR1	2.61e-04	4	139	2	GO:0014802
GeneOntologyCellularComponent	collagen type XI trimer	COL5A1 COL11A1	4.33e-04	5	139	2	GO:0005592
GeneOntologyCellularComponent	axonemal dynein complex	DNAH1 CFAP70 DNAH5	5.94e-04	25	139	3	GO:0005858
GeneOntologyCellularComponent	cytoplasmic region	UNC13B IFT140 LRRC43 DNAH1 GABARAPL1 UNC13C CFAP70 DNAH5 BRWD1	6.94e-04	360	139	9	GO:0099568
Domain	Atg8	MAP1LC3A GABARAPL1 MAP1LC3C	2.25e-05	8	140	3	PF02991
Domain	Atg8-like	MAP1LC3A GABARAPL1 MAP1LC3C	2.25e-05	8	140	3	IPR004241
Domain	-	NECAB2 SPTA1 ITSN1 PPP2R3B RYR1 PPP2R3A GUCA1A USP32 PLCE1	1.58e-04	261	140	9	1.10.238.10
Domain	Rhs_assc_core	TENM2 TENM4	1.67e-04	3	140	2	IPR022385
Domain	Unc-13	UNC13B UNC13C	1.67e-04	3	140	2	IPR027080
Domain	TPR_REGION	IFT140 ZFC3H1 VPS13A AIPL1 CFAP70 EMC2 TTC38	2.48e-04	165	140	7	PS50293
Domain	TPR	IFT140 ZFC3H1 VPS13A AIPL1 CFAP70 EMC2 TTC38	2.48e-04	165	140	7	PS50005
Domain	EF-hand-dom_pair	NECAB2 SPTA1 ITSN1 PPP2R3B RYR1 PPP2R3A GUCA1A USP32 PLCE1	3.19e-04	287	140	9	IPR011992
Domain	Tox-GHH_dom	TENM2 TENM4	3.31e-04	4	140	2	IPR028916
Domain	Tox-GHH	TENM2 TENM4	3.31e-04	4	140	2	PF15636
Domain	Ten_N	TENM2 TENM4	3.31e-04	4	140	2	IPR009471
Domain	Ten_N	TENM2 TENM4	3.31e-04	4	140	2	PF06484
Domain	TENEURIN_N	TENM2 TENM4	3.31e-04	4	140	2	PS51361
Domain	EF_hand_dom	NECAB2 SPTA1 ITSN1 PPP2R3B RYR1 PPP2R3A GUCA1A USP32	3.68e-04	232	140	8	IPR002048
Domain	TPR-like_helical_dom	SART3 IFT140 ZFC3H1 VPS41 AIPL1 CFAP70 EMC2 TTC38	3.78e-04	233	140	8	IPR011990
Domain	PRY	TRIM21 TRIM62 BTN1A1 BTN2A3P	4.56e-04	48	140	4	SM00589
Domain	PRY	TRIM21 TRIM62 BTN1A1 BTN2A3P	4.56e-04	48	140	4	IPR006574
Domain	C2	UNC13B ITSN1 DYSF PRKCA UNC13C PLCE1	4.62e-04	131	140	6	PF00168
Domain	SPRY	TRIM21 RYR1 TRIM62 BTN1A1 BTN2A3P	4.97e-04	87	140	5	SM00449
Domain	Munc13_dom-2	UNC13B UNC13C	5.50e-04	5	140	2	IPR014772
Domain	MHD2	UNC13B UNC13C	5.50e-04	5	140	2	PS51259
Domain	Munc13_subgr_dom-2	UNC13B UNC13C	5.50e-04	5	140	2	IPR019558
Domain	YD	TENM2 TENM4	5.50e-04	5	140	2	IPR006530
Domain	Membr_traf_MHD	UNC13B UNC13C	5.50e-04	5	140	2	PF10540
Domain	DUF1041	UNC13B UNC13C	5.50e-04	5	140	2	SM01145
Domain	C2	UNC13B ITSN1 DYSF PRKCA UNC13C PLCE1	5.86e-04	137	140	6	SM00239
Domain	PROTEIN_KINASE_ATP	PAK4 WNK1 MAP3K6 TXK IGF1R MARK4 CHEK2 MASTL PAK2 PRKCA ROS1	6.92e-04	459	140	11	PS00107
Domain	C2	UNC13B ITSN1 DYSF PRKCA UNC13C PLCE1	7.08e-04	142	140	6	PS50004
Domain	SPRY	TRIM21 RYR1 TRIM62 BTN1A1 BTN2A3P	7.08e-04	94	140	5	PF00622
Domain	SPRY_dom	TRIM21 RYR1 TRIM62 BTN1A1 BTN2A3P	7.08e-04	94	140	5	IPR003877
Domain	B30.2/SPRY	TRIM21 RYR1 TRIM62 BTN1A1 BTN2A3P	7.43e-04	95	140	5	IPR001870
Domain	B302_SPRY	TRIM21 RYR1 TRIM62 BTN1A1 BTN2A3P	7.43e-04	95	140	5	PS50188
Domain	MA3	CWC22 EIF4G1	8.20e-04	6	140	2	SM00544
Domain	MA3	CWC22 EIF4G1	8.20e-04	6	140	2	PF02847
Domain	PAK_BD	PAK4 PAK2	8.20e-04	6	140	2	IPR033923
Domain	Initiation_fac_eIF4g_MI	CWC22 EIF4G1	8.20e-04	6	140	2	IPR003891
Domain	MI	CWC22 EIF4G1	8.20e-04	6	140	2	PS51366
Domain	-	UNC13B ITSN1 DYSF PRKCA UNC13C PLCE1	8.78e-04	148	140	6	2.60.40.150
Domain	TPR-contain_dom	IFT140 ZFC3H1 VPS13A AIPL1 CFAP70 EMC2	9.42e-04	150	140	6	IPR013026
Domain	Munc13_1	UNC13B UNC13C	1.14e-03	7	140	2	IPR014770
Domain	WASP_C	PAK4 PAK2	1.14e-03	7	140	2	IPR011026
Domain	MHD1	UNC13B UNC13C	1.14e-03	7	140	2	PS51258
Domain	Peptidase_M13_C	PHEX ECE2	1.14e-03	7	140	2	IPR018497
Domain	Peptidase_M13	PHEX ECE2	1.14e-03	7	140	2	IPR000718
Domain	Peptidase_M13_N	PHEX ECE2	1.14e-03	7	140	2	PF05649
Domain	Peptidase_M13_N	PHEX ECE2	1.14e-03	7	140	2	IPR008753
Domain	DUF1041	UNC13B UNC13C	1.14e-03	7	140	2	PF06292
Domain	CAPS_dom	UNC13B UNC13C	1.14e-03	7	140	2	IPR010439
Domain	Peptidase_M13	PHEX ECE2	1.14e-03	7	140	2	PF01431
Domain	Prot_kinase_dom	PAK4 WNK1 MAP3K6 TXK IGF1R MARK4 CHEK2 MASTL PAK2 PRKCA ROS1	1.16e-03	489	140	11	IPR000719
Domain	PROTEIN_KINASE_DOM	PAK4 WNK1 MAP3K6 TXK IGF1R MARK4 CHEK2 MASTL PAK2 PRKCA ROS1	1.23e-03	493	140	11	PS50011
Domain	ConA-like_dom	COL5A1 COL11A1 TRIM21 RYR1 CELSR1 TRIM62 BTN1A1	1.33e-03	219	140	7	IPR013320
Domain	C2_dom	UNC13B ITSN1 DYSF PRKCA UNC13C PLCE1	1.49e-03	164	140	6	IPR000008
Domain	AC_N	ADCY3 ADCY8	1.52e-03	8	140	2	IPR032628
Domain	Adcy	ADCY3 ADCY8	1.52e-03	8	140	2	IPR030672
Domain	AC_N	ADCY3 ADCY8	1.52e-03	8	140	2	PF16214
Domain	EF_HAND_2	NECAB2 SPTA1 ITSN1 PPP2R3B PPP2R3A GUCA1A USP32	1.81e-03	231	140	7	PS50222
Domain	Butyrophylin	TRIM21 TRIM62 BTN1A1 BTN2A3P	1.89e-03	70	140	4	IPR003879
Domain	EF_Hand_1_Ca_BS	NECAB2 ITSN1 PPP2R3B PPP2R3A GUCA1A USP32	2.07e-03	175	140	6	IPR018247
Domain	MIF4G	CWC22 EIF4G1	2.41e-03	10	140	2	SM00543
Domain	JmjN	KDM4E KDM4B	2.41e-03	10	140	2	SM00545
Domain	MIF4G	CWC22 EIF4G1	2.41e-03	10	140	2	PF02854
Domain	JmjN	KDM4E KDM4B	2.41e-03	10	140	2	PF02375
Domain	HAT	SART3 ZFC3H1	2.41e-03	10	140	2	SM00386
Domain	MIF4G-like_typ-3	CWC22 EIF4G1	2.41e-03	10	140	2	IPR003890
Domain	JMJN	KDM4E KDM4B	2.41e-03	10	140	2	PS51183
Domain	HAT	SART3 ZFC3H1	2.41e-03	10	140	2	IPR003107
Domain	JmjN	KDM4E KDM4B	2.41e-03	10	140	2	IPR003349
Domain	Kinase-like_dom	PAK4 WNK1 MAP3K6 TXK IGF1R MARK4 CHEK2 MASTL PAK2 PRKCA ROS1	2.59e-03	542	140	11	IPR011009
Domain	NC1_FIB	COL5A1 COL11A1	2.94e-03	11	140	2	PS51461
Domain	Fib_collagen_C	COL5A1 COL11A1	2.94e-03	11	140	2	PD002078
Domain	Fib_collagen_C	COL5A1 COL11A1	2.94e-03	11	140	2	IPR000885
Domain	COLFI	COL5A1 COL11A1	2.94e-03	11	140	2	PF01410
Domain	Tyr_kinase_rcpt_2_CS	IGF1R ROS1	2.94e-03	11	140	2	IPR002011
Domain	COLFI	COL5A1 COL11A1	2.94e-03	11	140	2	SM00038
Domain	-	TENM2 TENM4 ROS1	3.09e-03	39	140	3	2.120.10.30
Domain	Laminin_G_2	COL5A1 COL11A1 CELSR1	3.33e-03	40	140	3	PF02210
Domain	-	PAK4 PAK2	3.51e-03	12	140	2	3.90.810.10
Domain	APOBEC_N	APOBEC3B APOBEC3C	3.51e-03	12	140	2	PF08210
Domain	RECEPTOR_TYR_KIN_II	IGF1R ROS1	3.51e-03	12	140	2	PS00239
Domain	Peptidase_M1	ANPEP AOPEP	3.51e-03	12	140	2	IPR001930
Domain	APOBEC_N	APOBEC3B APOBEC3C	3.51e-03	12	140	2	IPR013158
Domain	PRY	TRIM21 TRIM62 BTN1A1	3.82e-03	42	140	3	PF13765
Domain	Peptidase_M1_N	ANPEP AOPEP	4.12e-03	13	140	2	IPR014782
Domain	Peptidase_M1	ANPEP AOPEP	4.12e-03	13	140	2	PF01433
Domain	NHL	TENM2 TENM4	4.12e-03	13	140	2	PS51125
Domain	LamG	COL5A1 COL11A1 CELSR1	4.36e-03	44	140	3	SM00282
Domain	EF_HAND_1	NECAB2 ITSN1 PPP2R3B PPP2R3A GUCA1A USP32	4.41e-03	204	140	6	PS00018
Domain	Dynein_heavy_chain_D4_dom	DNAH1 DNAH5	4.79e-03	14	140	2	IPR024317
Domain	Dynein_HC_stalk	DNAH1 DNAH5	4.79e-03	14	140	2	IPR024743
Domain	Dynein_heavy_dom-2	DNAH1 DNAH5	4.79e-03	14	140	2	IPR013602
Domain	DHC_N2	DNAH1 DNAH5	4.79e-03	14	140	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH1 DNAH5	4.79e-03	14	140	2	IPR011704
Domain	MT	DNAH1 DNAH5	4.79e-03	14	140	2	PF12777
Domain	AAA_8	DNAH1 DNAH5	4.79e-03	14	140	2	PF12780
Domain	APOBEC/CMP_deaminase_Zn-bd	APOBEC3B APOBEC3C	4.79e-03	14	140	2	IPR016192
Domain	AAA_5	DNAH1 DNAH5	4.79e-03	14	140	2	PF07728
Domain	6-blade_b-propeller_TolB-like	TENM2 TENM4 ROS1	4.94e-03	46	140	3	IPR011042
Domain	DHC_fam	DNAH1 DNAH5	5.49e-03	15	140	2	IPR026983
Domain	-	CWC22 EIF4G1	5.49e-03	15	140	2	1.25.40.180
Pubmed	TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity.	MAP1LC3A TRIM21 NLRP3 GABARAPL1 MAP1LC3C	1.13e-08	19	141	5	26347139
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B SEMA3F EPPK1 CEP192 WRAP53 DYSF WNK1 RYR1 MYORG TIAM2 CELSR1 IGF1R UBN1 KLHL21 SUMF1 MARK4 EIF4G1 TTC38 SDHA	1.21e-07	1105	141	19	35748872
Pubmed	An ALS-associated variant of the autophagy receptor SQSTM1/p62 reprograms binding selectivity toward the autophagy-related hATG8 proteins.	MAP1LC3A GABARAPL1 MAP1LC3C	2.26e-06	7	141	3	34929165
Pubmed	Viral Infection-Induced Differential Expression of LncRNAs Associated with Collagen in Mouse Placentas and Amniotic Sacs.	COL5A1 WNK1 SLC6A12 SYCP2 TRPM8 TRPM1	3.48e-06	100	141	6	26073538
Pubmed	Autophagy receptor NDP52 regulates pathogen-containing autophagosome maturation.	MAP1LC3A GABARAPL1 MAP1LC3C	3.60e-06	8	141	3	25771791
Pubmed	TRIM32, but not its muscular dystrophy-associated mutant, positively regulates and is targeted to autophagic degradation by p62/SQSTM1.	MAP1LC3A GABARAPL1 MAP1LC3C	3.60e-06	8	141	3	31685529
Pubmed	Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagy.	MAP1LC3A GABARAPL1 MAP1LC3C	3.60e-06	8	141	3	31971854
Pubmed	DOR/Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding dual regulators of autophagy and transcription.	MAP1LC3A GABARAPL1 MAP1LC3C	3.60e-06	8	141	3	22470510
Pubmed	Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins.	MAP1LC3A GABARAPL1 MAP1LC3C	5.38e-06	9	141	3	29867141
Pubmed	The E3 ubiquitin ligase NEDD4 enhances killing of membrane-perturbing intracellular bacteria by promoting autophagy.	MAP1LC3A GABARAPL1 MAP1LC3C	5.38e-06	9	141	3	29251248
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B ZBTB43 CEP192 CSMD3 TENM2 ADCY3 TENM4 ZNF451 MARK4 PLCE1	6.83e-06	407	141	10	12693553
Pubmed	A role for NBR1 in autophagosomal degradation of ubiquitinated substrates.	MAP1LC3A GABARAPL1 MAP1LC3C	7.67e-06	10	141	3	19250911
Pubmed	The IAP family member BRUCE regulates autophagosome-lysosome fusion.	MAP1LC3A GABARAPL1 MAP1LC3C	7.67e-06	10	141	3	29426817
Pubmed	HUWE1 E3 ligase promotes PINK1/PARKIN-independent mitophagy by regulating AMBRA1 activation via IKKα.	MAP1LC3A GABARAPL1 MAP1LC3C	7.67e-06	10	141	3	30217973
Pubmed	ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of mammalian orthologs of yeast Atg8.	MAP1LC3A GABARAPL1 MAP1LC3C	7.67e-06	10	141	3	28287329
Pubmed	ATG8 family proteins act as scaffolds for assembly of the ULK complex: sequence requirements for LC3-interacting region (LIR) motifs.	MAP1LC3A GABARAPL1 MAP1LC3C	1.05e-05	11	141	3	23043107
Pubmed	Methods for Studying Interactions Between Atg8/LC3/GABARAP and LIR-Containing Proteins.	MAP1LC3A GABARAPL1 MAP1LC3C	1.05e-05	11	141	3	28253953
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	SEMA3F COL11A1 EPPK1 PSMB5 EIF3E TRIM21 TIAM2 KLHL21 EIF4G1 ROS1 OSTF1 SDHA EXOC4	1.31e-05	754	141	13	35906200
Pubmed	Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.	PRKCA PLCE1	1.63e-05	2	141	2	28402280
Pubmed	The Effect of PKCα on the Light Response of Rod Bipolar Cells in the Mouse Retina.	PRKCA TRPM1	1.63e-05	2	141	2	26230760
Pubmed	Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma.	APOBEC3B APOBEC3C	1.63e-05	2	141	2	25650088
Pubmed	Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia.	CASQ1 RYR1	1.63e-05	2	141	2	28465322
Pubmed	Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G.	APOBEC3B APOBEC3C	1.63e-05	2	141	2	16060832
Pubmed	TRIM62 knockout protects against cerebral ischemic injury in mice by suppressing NLRP3-regulated neuroinflammation.	NLRP3 TRIM62	1.63e-05	2	141	2	32703402
Pubmed	Structure of a full-length cDNA clone for the pro-alpha1(V/XI) collagen chain of red seabream.	COL5A1 COL11A1	1.63e-05	2	141	2	11342118
Pubmed	Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses.	UNC13B UNC13C	1.63e-05	2	141	2	22674279
Pubmed	APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.	APOBEC3B APOBEC3C	1.63e-05	2	141	2	15466872
Pubmed	Oxygen Consumption and Basal Metabolic Rate as Markers of Susceptibility to Malignant Hyperthermia and Heat Stroke.	CASQ1 RYR1	1.63e-05	2	141	2	36010545
Pubmed	[Expression and significance of IGF-IR and PKC in laryngeal squamous cell carcinoma].	IGF1R PRKCA	1.63e-05	2	141	2	20422977
Pubmed	WNK1 is an assembly factor for the human ER membrane protein complex.	WNK1 EMC2	1.63e-05	2	141	2	33964204
Pubmed	Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.	APOBEC3B APOBEC3C	1.63e-05	2	141	2	26682542
Pubmed	APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA.	APOBEC3B APOBEC3C	1.63e-05	2	141	2	34181944
Pubmed	Identification of PKCα-dependent phosphoproteins in mouse retina.	PRKCA TRPM1	1.63e-05	2	141	2	31255707
Pubmed	Expression of truncated eukaryotic initiation factor 3e (eIF3e) resulting from integration of mouse mammary tumor virus (MMTV) causes a shift from cap-dependent to cap-independent translation.	EIF3E EIF4G1	1.63e-05	2	141	2	21737453
Pubmed	The IGF-I receptor can alter the matrix metalloproteinase repertoire of tumor cells through transcriptional regulation of PKC-{alpha}.	IGF1R PRKCA	1.63e-05	2	141	2	19855090
Pubmed	Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases.	ANO4 APOBEC3B ADCY8 APOBEC3C	1.91e-05	39	141	4	24709693
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	ZCCHC9 CNST CEP192 WNK1 UBN1	1.92e-05	80	141	5	19389623
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PAK4 EIF3E CEP192 CUL7 BCAR1 MAP3K6 IGF1R GABARAPL1 ANAPC1 EIF4G1 CHEK2 PRKCA OSTF1 PIP4K2C	2.14e-05	910	141	14	36736316
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	ANPEP CD109 TRIM21 CUL7 RYR1 BTN1A1 DNAH5	2.85e-05	214	141	7	22199357
Pubmed	CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.	MAP1LC3A GABARAPL1 MAP1LC3C	2.86e-05	15	141	3	35366418
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DHX40 ITSN1 CEP192 CUL7 BCAR1 WNK1 UBN1 ANAPC1 ZNF451 PIP4K2C EXOC4	2.98e-05	588	141	11	38580884
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 COL5A1 EOGT CEP192 BCAR1 ADCY3 DNAH1 PPP2R3A AP1S1 IGF1R THEM4 AOPEP VPS41 OSTF1 OLFM2 KDM4B DOP1A EXOC4	3.49e-05	1489	141	18	28611215
Pubmed	The cleavage of host cell proteins by HIV-1 protease.	SPTA1 MAP1LC3A MAP1LC3C	4.25e-05	17	141	3	8997639
Pubmed	Growth Hormone Receptor Deficiency Protects against Age-Related NLRP3 Inflammasome Activation and Immune Senescence.	NLRP3 IGF1R	4.88e-05	3	141	2	26876170
Pubmed	MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis-Brief Report.	NLRP3 MARK4	4.88e-05	3	141	2	31167564
Pubmed	Protein phosphatase 2A interacts with the Src kinase substrate p130(CAS).	PPP2R3B BCAR1	4.88e-05	3	141	2	11593413
Pubmed	A new PKCα/β/TBX3/E-cadherin pathway is involved in PLCε-regulated invasion and migration in human bladder cancer cells.	PRKCA PLCE1	4.88e-05	3	141	2	24316392
Pubmed	Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death.	CASQ1 RYR1	4.88e-05	3	141	2	24143248
Pubmed	Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.	IGF1R SDHA	4.88e-05	3	141	2	23109135
Pubmed	Calcium-mediated, purinergic stimulation and polarized localization of calcium-sensitive adenylyl cyclase isoforms in human airway epithelia.	ADCY3 ADCY8	4.88e-05	3	141	2	17586501
Pubmed	LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.	MAP1LC3A MAP1LC3C	4.88e-05	3	141	2	27880899
Pubmed	A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line.	ADCY3 ADCY8	4.88e-05	3	141	2	8476432
Pubmed	Alteration of autophagosomal proteins in the brain of multiple system atrophy.	MAP1LC3A GABARAPL1	4.88e-05	3	141	2	22959883
Pubmed	Distinct regions of triadin are required for targeting and retention at the junctional domain of the sarcoplasmic reticulum.	CASQ1 RYR1	4.88e-05	3	141	2	24325401
Pubmed	MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.	NLRP3 MARK4	4.88e-05	3	141	2	28656979
Pubmed	Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e subunit.	EIF3E EIF4G1	4.88e-05	3	141	2	16766523
Pubmed	Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B.	MAP1LC3A MAP1LC3C	4.88e-05	3	141	2	12740394
Pubmed	Tripartite-motif protein 21 knockdown extenuates LPS-triggered neurotoxicity by inhibiting microglial M1 polarization via suppressing NF-κB-mediated NLRP3 inflammasome activation.	TRIM21 NLRP3	4.88e-05	3	141	2	33992596
Pubmed	Heterogeneous Presynaptic Distribution of Munc13 Isoforms at Retinal Synapses and Identification of an Unconventional Bipolar Cell Type with Dual Expression of Munc13 Isoforms: A Study Using Munc13-EXFP Knock-in Mice.	UNC13B UNC13C	4.88e-05	3	141	2	33105896
Pubmed	cDNA sequence and expression of the mouse alpha1(V) collagen gene (Col5a1).	COL5A1 COL11A1	4.88e-05	3	141	2	9582436
Pubmed	Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1.	EIF4G1 PRKCA	4.88e-05	3	141	2	21576361
Pubmed	Novel Insights into the Cellular Localization and Regulation of the Autophagosomal Proteins LC3A, LC3B and LC3C.	MAP1LC3A MAP1LC3C	4.88e-05	3	141	2	33081014
Pubmed	p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.	PAK4 PAK2	4.88e-05	3	141	2	26218748
Pubmed	The Association of Variants within Types V and XI Collagen Genes with Knee Joint Laxity Measurements.	COL5A1 COL11A1	4.88e-05	3	141	2	36553626
Pubmed	Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	35902635
Pubmed	Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein.	PPP2R3B PPP2R3A	4.88e-05	3	141	2	9927208
Pubmed	Genetic variants and susceptibility to neurological complications following West Nile virus infection.	ANPEP RFC1	4.88e-05	3	141	2	21881118
Pubmed	Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	39150943
Pubmed	Opposing roles of PAK2 and PAK4 in synergistic induction of MUC5AC mucin by bacterium NTHi and EGF.	PAK4 PAK2	4.88e-05	3	141	2	17555715
Pubmed	The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.	UNC13B UNC13C	4.88e-05	3	141	2	23658173
Pubmed	Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.	CASQ1 DYSF	4.88e-05	3	141	2	23792176
Pubmed	Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	10469298
Pubmed	Association Between COL5a1, COL11a1, and COL11a2 Gene Variations and Rotator Cuff Tendinopathy in Young Athletes.	COL5A1 COL11A1	4.88e-05	3	141	2	34009784
Pubmed	Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	27643540
Pubmed	Phosphorylation of Mnk1 by caspase-activated Pak2/gamma-PAK inhibits phosphorylation and interaction of eIF4G with Mnk.	EIF4G1 PAK2	4.88e-05	3	141	2	15234964
Pubmed	Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	16414984
Pubmed	Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans.	ANPEP IGF1R	4.88e-05	3	141	2	19330903
Pubmed	The Insulin Receptor and Insulin like Growth Factor Receptor 5' UTRs Support Translation Initiation Independently of EIF4G1.	IGF1R EIF4G1	4.88e-05	3	141	2	37724583
Pubmed	Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.	APOBEC3B APOBEC3C	4.88e-05	3	141	2	28637869
Pubmed	A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L.	MAP1LC3A GABARAPL1	4.88e-05	3	141	2	14530254
Pubmed	Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney.	GGT2P GGT3P	4.88e-05	3	141	2	2573352
Pubmed	Nonconserved Ca(2+)/calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity.	UNC13B UNC13C	4.88e-05	3	141	2	22966208
Pubmed	Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse.	UNC13B UNC13C	4.88e-05	3	141	2	15988013
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	EPPK1 ITSN1 TMEM151B BCAR1 UBN1 EIF4G1 UGCG DNAH5	6.68e-05	332	141	8	37433992
Pubmed	TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition.	MAP1LC3A GABARAPL1 MAP1LC3C	7.07e-05	20	141	3	25127057
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	IFT140 ZFC3H1 ADCY3 ZNF451 ECE2	7.11e-05	105	141	5	9628581
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	ITSN1 MAP1LC3A GABARAPL1 MAP1LC3C CHEK2	8.87e-05	110	141	5	37219487
Pubmed	Diversity in genomic organisation, developmental regulation and distribution of the murine PR72/B" subunits of protein phosphatase 2A.	PPP2R3B PPP2R3A	9.74e-05	4	141	2	18715506
Pubmed	Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse.	COL5A1 COL11A1	9.74e-05	4	141	2	17683922
Pubmed	Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues.	TENM2 TENM4	9.74e-05	4	141	2	10225957
Pubmed	Association with PAK2 Enables Functional Interactions of Lentiviral Nef Proteins with the Exocyst Complex.	PAK2 EXOC4	9.74e-05	4	141	2	26350970
Pubmed	Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure.	PAK2 PRKCA	9.74e-05	4	141	2	2500966
Pubmed	The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets.	MAP1LC3A MAP1LC3C	9.74e-05	4	141	2	37443287
Pubmed	Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia.	DNAH1 DNAH5	9.74e-05	4	141	2	18492703
Pubmed	Novel axonemal protein ZMYND12 interacts with TTC29 and DNAH1, and is required for male fertility and flagellum function.	DNAH1 CFAP70	9.74e-05	4	141	2	37934199
Pubmed	Pak to the future.	PAK4 PAK2	9.74e-05	4	141	2	10461188
Pubmed	HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates.	MAP1LC3A MAP1LC3C	9.74e-05	4	141	2	15187094
Pubmed	PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.	PAK4 PAK2	9.74e-05	4	141	2	9822598
Pubmed	Species-specific restriction of apobec3-mediated hypermutation.	APOBEC3B APOBEC3C	9.74e-05	4	141	2	18032489
Pubmed	Human eukaryotic initiation factor 4G (eIF4G) protein binds to eIF3c, -d, and -e to promote mRNA recruitment to the ribosome.	EIF3E EIF4G1	9.74e-05	4	141	2	24092755
Cytoband	5p15	SRD5A1 SDHA	1.95e-04	7	141	2	5p15
Cytoband	Ensembl 112 genes in cytogenetic band chr8q23	EIF3E CSMD3 EMC2	5.30e-04	51	141	3	chr8q23
Cytoband	Ensembl 112 genes in cytogenetic band chr12q23	ANO4 SART3 ALDH1L2 ACTR6	1.22e-03	150	141	4	chr12q23
Cytoband	9q31	FRRS1L UGCG	1.24e-03	17	141	2	9q31
Cytoband	4p12	ATP10D TXK	1.72e-03	20	141	2	4p12
Cytoband	6p21.1	TMEM151B CUL7 GUCA1A	1.96e-03	80	141	3	6p21.1
Cytoband	3p14.1	MAGI1 EOGT	2.47e-03	24	141	2	3p14.1
Cytoband	1q21	SPTA1 CASQ1 THEM4	2.83e-03	91	141	3	1q21
Cytoband	Ensembl 112 genes in cytogenetic band chr4p12	ATP10D TXK	2.90e-03	26	141	2	chr4p12
Cytoband	Ensembl 112 genes in cytogenetic band chr22q13	APOBEC3B TUBGCP6 CELSR1 APOBEC3C TTC38	3.63e-03	330	141	5	chr22q13
GeneFamily	UNC13 homologs	UNC13B UNC13C	1.99e-04	4	105	2	836
GeneFamily	EF-hand domain containing	NECAB2 SPTA1 ITSN1 PPP2R3B PPP2R3A GUCA1A USP32	2.90e-04	219	105	7	863
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	ZCCHC9 CNST CEP192 WNK1 RYR1 UBN1	6.57e-04	181	105	6	694
GeneFamily	Autophagy related	MAP1LC3A GABARAPL1 MAP1LC3C	9.15e-04	33	105	3	1022
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY3 ADCY8	1.46e-03	10	105	2	53
GeneFamily	Apolipoprotein B mRNA editing enzyme catalytic subunits	APOBEC3B APOBEC3C	2.12e-03	12	105	2	406
GeneFamily	Collagens	COL5A1 COL11A1 COL6A5	2.41e-03	46	105	3	490
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT2P GGT3P	2.50e-03	13	105	2	564
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R3B PPP2R3A	3.34e-03	15	105	2	696
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN1A1 BTN2A3P	3.34e-03	15	105	2	458
GeneFamily	Dyneins, axonemal	DNAH1 DNAH5	4.29e-03	17	105	2	536
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CSMD3 DNAH1 SYCP2 TENM4 UNC13C ROS1 DNAH5 PLCE1	3.98e-10	184	141	10	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CSMD3 DNAH1 SYCP2 TENM4 UNC13C ROS1 DNAH5 PLCE1	3.98e-10	184	141	10	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL11A1 SPTA1 CSMD3 DNAH1 SYCP2 TENM4 UNC13C ROS1 DNAH5 PLCE1	3.98e-10	184	141	10	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NPR3 COL11A1 COL6A5 TENM2 TIAM2 ZFYVE28 SLC7A3	7.04e-07	157	141	7	1f21d78a467fe22c5ab75d0917b840c1ac93f32c
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13B TSPAN15 SEMA3F DPYS FAAH SLC7A3 ALDH1L2	2.03e-06	184	141	7	1e54fd372c6e6a298f427b807c14cc49aaaffe80
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANPEP CASQ1 RYR1 DNAH1 CIITA DOP1A	1.55e-05	167	141	6	f33cef917fa733adf6d5a9a9e989a4d9fd462a8f
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 CSMD3 DNAH1 TRPM8 UNC13C DNAH5	1.66e-05	169	141	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL5A1 COL6A5 CEP192 TENM4 CIITA KDM4B	1.71e-05	170	141	6	ba4ba66b624089ed50a9083176386c7941b4c7a3
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	COL5A1 PCDHGA7 MYORG PHEX DUSP29 ALDH1L2	2.52e-05	182	141	6	ba066ff9029cc052b76e2330ec168cb2e9b7e498
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANO4 TSPAN15 SRD5A1 CUL7 GABARAPL1 PAK2	2.84e-05	186	141	6	39e475a3c167b33daa63b0c1bfa32451c5f46635
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B MAGI1 GSAP CELSR1 ROS1 DNAH5	2.84e-05	186	141	6	2ea5ff14861e5f91d0e6a5767c403a24045d715c
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANO4 TSPAN15 SRD5A1 CUL7 GABARAPL1 PAK2	2.84e-05	186	141	6	02418c50fdcca549bf73dedf6199ab4a27862a9b
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B MAGI1 GSAP ADCY8 GGT2P ROS1	3.20e-05	190	141	6	8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B MAGI1 COL11A1 ADCY8 GGT2P ROS1	3.30e-05	191	141	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Leuk-UTI-Lymphocyte-T_NK-CD4_Naive\|Leuk-UTI / Disease, Lineage and Cell Type	EPPK1 EIF3E TXK THEM4 PRKCA OLFM2	3.39e-05	192	141	6	ecdcb210a448495fc141ddc946cca1fbd821ad83
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B MAGI1 COL11A1 ADCY8 GGT2P ROS1	3.39e-05	192	141	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	Healthy/Control-CD4+_T_naive\|Healthy/Control / Disease group and Cell class	EPPK1 EIF3E TXK IGF1R THEM4 PRKCA	3.49e-05	193	141	6	f5face746df3517c86d72e31ba8f1b78c4c6b481
ToppCell	Healthy/Control-CD4+_T_naive\|World / Disease group and Cell class	EPPK1 EIF3E TXK IGF1R THEM4 PRKCA	3.49e-05	193	141	6	6218e6cbe44d92bb98d42ef2f5e18ab7a683b100
ToppCell	Healthy_donor-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	EPPK1 EIF3E TXK IGF1R THEM4 PRKCA	3.60e-05	194	141	6	bcaaa6b6ce5b3552f11311d8ee91c35b8ec065f8
ToppCell	Healthy_donor-CD4+_T_naive\|Healthy_donor / disease group, cell group and cell class (v2)	EPPK1 EIF3E TXK IGF1R THEM4 PRKCA	3.60e-05	194	141	6	a8a0368a4e0eb5654fdffc8a779b08ad402aa2eb
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GSDMC CELSR1 TENM4 UGCG DNAH5 PLCE1	3.81e-05	196	141	6	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GSDMC CELSR1 TENM4 UGCG DNAH5 PLCE1	3.81e-05	196	141	6	c366f980cc04abfe1c0c14746c11810c812a42c0
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B MAGI1 IGF1R AOPEP PRKCA EXOC4	4.03e-05	198	141	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_T_naive\|Leuk-UTI / Disease, condition lineage and cell class	EPPK1 EIF3E TXK THEM4 PRKCA OLFM2	4.26e-05	200	141	6	a542c302ac266ed0ead355b5011f0aff39320ed7
ToppCell	COVID-19_Mild-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	HLF BCAR1 DUSP29 UNC13C DNAH5	4.88e-05	125	141	5	e58c208b4355252ceabe04a468dd19a1f436182c
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	HLF WNK1 PPP2R3A AP1S1 GABARAPL1 MARK4 EIF4G1 UGCG APOBEC3C KDM4B	3.25e-07	191	141	10	6644_DN
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	COL5A1 EPPK1 ZBTB43 WRAP53 ATP10D PPP2R3A AP1S1 CHEK2 BRWD1	3.80e-06	196	141	9	2051_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A	IFT140 NPR3 AP1S1 GABARAPL1 TRIM62 VPS13A TTC38 KDM4B BRWD1	3.80e-06	196	141	9	7155_UP
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A	IFT140 NPR3 ANPEP CHRNB2 SLC2A5 AP1S1 GABARAPL1 AOPEP KDM4B	3.96e-06	197	141	9	3910_UP
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ZBTB43 WRAP53 WNK1 PPP2R3A IGF1R EIF4G1 UGCG BRWD1	2.31e-05	188	141	8	4845_DN
Drug	Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A	ZBTB43 WNK1 IGF1R UBN1 UGCG KDM4B DOP1A BRWD1	2.40e-05	189	141	8	1288_DN
Drug	alpha-Santonin [481-06-1]; Up 200; 16.2uM; PC3; HT_HG-U133A	COL5A1 HLF CUL7 TXK PHEX VPS41 TRPM1 DOP1A	2.90e-05	194	141	8	4531_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	COL5A1 NPR3 EPPK1 ZBTB43 CUL7 MAP3K6 AP1S1 MARK4	3.00e-05	195	141	8	5117_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A	ZBTB43 TRIM21 CUL7 ATP10D AP1S1 TRIM62 VPS13A BRWD1	3.12e-05	196	141	8	2066_DN
Drug	(-)-Eseroline fumarate salt [104015-29-4]; Up 200; 12uM; PC3; HT_HG-U133A	SEMA3F NPR3 CUL7 PHEX GABARAPL1 RNF146 MARK4 OSTF1	3.23e-05	197	141	8	7267_UP
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; HL60; HT_HG-U133A	EOGT TCN1 WNK1 NLRP3 SYCP2 MARK4 UGCG PRKCA	3.23e-05	197	141	8	2909_DN
Drug	Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; MCF7; HT_HG-U133A	SEMA3F IFT140 CUL7 FAAH PHEX SYCP2 MARK4 TTC38	3.35e-05	198	141	8	2297_DN
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	COL5A1 NPR3 GSAP WNK1 PHEX AP1S1 MARK4 APOBEC3C	3.35e-05	198	141	8	5414_UP
Drug	Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; HL60; HT_HG-U133A	WRAP53 DYSF WNK1 ADCY3 MARK4 VPS13A APOBEC3C TTC38	3.60e-05	200	141	8	2939_DN
Disease	age at menarche	COL11A1 HLF TENM2 ADCY3 ADCY8 IGF1R EIF4G1 UNC13C OLFM2 KDM4B ECE2 BRWD1	2.99e-05	594	141	12	EFO_0004703
Disease	height-adjusted body mass index	ADCY3 ADCY8	6.78e-05	3	141	2	EFO_0005851
Disease	Tourette syndrome	CSMD3 TENM2 PHEX TENM4	9.70e-05	50	141	4	EFO_0004895
Disease	IGF-1 measurement	IFT140 HLF EIF3E PPP2R3A AOPEP RNF146 PRKCA AKAP10 PIP4K2C KDM4B	1.25e-04	488	141	10	EFO_0004627
Disease	Drug habituation	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0013170
Disease	Drug abuse	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0013146
Disease	Prescription Drug Abuse	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C4316881
Disease	Substance-Related Disorders	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0236969
Disease	Drug Use Disorders	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0013222
Disease	Drug Dependence	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C1510472
Disease	Substance Dependence	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0038580
Disease	Substance Use Disorders	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	ANO4 CSMD3 TENM2 FAAH TIAM2	2.34e-04	115	141	5	C0029231
Disease	Substance abuse problem	ANO4 CSMD3 TENM2 FAAH TIAM2	2.43e-04	116	141	5	C0740858
Disease	neutrophil count	TSPAN15 MAGI1 COL11A1 POLR3GL DARS1 CHRNB2 NLRP3 RRAGC THEM4 MARK4 UGCG BTN2A3P CHEK2 PAK2 AKAP10 UNC13C KDM4B	3.33e-04	1382	141	17	EFO_0004833
Disease	metabolite measurement	DPYS COL11A1 SPTA1 BAAT ATP10D FAAH TUBGCP6 SLC6A12 THEM4 TTC38	3.75e-04	560	141	10	EFO_0004725
Disease	COVID-19, obesity	ADCY3 ADCY8	4.69e-04	7	141	2	EFO_0001073, MONDO_0100096
Disease	glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement	ATP10D TXK	4.69e-04	7	141	2	EFO_0800520
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT2P GGT3P	4.69e-04	7	141	2	DOID:5022 (biomarker_via_orthology)
Disease	cesarean section, Self-injurious behavior	ANPEP CELSR1 EXOC4	4.79e-04	32	141	3	EFO_0009636, HP_0100716
Disease	age at first sexual intercourse measurement	SEMA3F TENM2 TENM4 SUMF1 BTN1A1 KDM4B EXOC4 BRWD1	5.30e-04	383	141	8	EFO_0009749
Disease	reticulocyte measurement	TSPAN15 SEMA3F SPTA1 PSMB5 RFC1 ADCY3 ADCY8 MARK4 USP32 EIF4G1 VPS13A CHEK2 PAK2 CFAP70	5.39e-04	1053	141	14	EFO_0010700
Disease	pneumococcal meningitis	CELSR1 ROS1	6.23e-04	8	141	2	EFO_1001114
Disease	alcohol dependence (biomarker_via_orthology)	GGT2P GGT3P	6.23e-04	8	141	2	DOID:0050741 (biomarker_via_orthology)
Disease	non-alcoholic fatty liver disease (implicated_via_orthology)	NLRP3 SLC7A3 ALDH1L2	6.79e-04	36	141	3	DOID:0080208 (implicated_via_orthology)
Disease	glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement	ATP10D TXK	7.98e-04	9	141	2	EFO_0800476
Disease	hemoglobin A1 measurement	SPTA1 ITSN1 PSMB5 GSAP RFC1 KLHL21 VPS13A PAK2 APOBEC3C	9.18e-04	520	141	9	EFO_0007629
Disease	Parkinson's disease (implicated_via_orthology)	PAK4 IGF1R EIF4G1 VPS13A VPS41	9.67e-04	157	141	5	DOID:14330 (implicated_via_orthology)
Disease	aspartate aminotransferase to alanine aminotransferase ratio	EPPK1 ANPEP LRRC43 MARK4 CHEK2 PRKCA	1.05e-03	239	141	6	EFO_0010934
Disease	QT interval	ITSN1 HLF FAM13B SLC2A5 AOPEP PRKCA ROS1 EXOC4 BRWD1	1.11e-03	534	141	9	EFO_0004682
Disease	insulin sensitivity measurement, glucose homeostasis measurement	PAK2 UNC13C PLCE1	1.15e-03	43	141	3	EFO_0004471, EFO_0006896
Disease	JT interval	FAM13B IGF1R AOPEP PRKCA CFAP70 BRWD1	1.26e-03	248	141	6	EFO_0007885
Disease	anthropometric measurement	NPR3 COL11A1 TENM2 IGF1R DUSP29	1.31e-03	168	141	5	EFO_0004302
Disease	empathy measurement	ZCCHC9 DYSF TENM4 METTL9 SUMF1	1.38e-03	170	141	5	EFO_0009183
Disease	progression free survival, urinary bladder cancer	IFT140 TENM4	1.45e-03	12	141	2	EFO_0004920, MONDO_0001187
Disease	monocyte count	GALNT1 SPTA1 OSER1 DARS1 WNK1 RYR1 CHRNB2 ZFYVE28 THEM4 CIITA MARK4 BTN2A3P PAK2 KDM4B PLCE1	1.66e-03	1320	141	15	EFO_0005091
Disease	Malignant neoplasm of breast	COL11A1 CD109 BCAR1 DYSF WNK1 MAP3K6 APOBEC3B FAAH SLC2A5 METTL6 IGF1R CHEK2 DOP1A	1.97e-03	1074	141	13	C0006142
Disease	Tubular Aggregate Myopathy	CASQ1 RYR1	1.99e-03	14	141	2	C0410207
Disease	Colorectal Carcinoma	UNC13B CD109 WNK1 CSMD3 ADCY8 EIF4G1 VPS13A CHEK2 OLFM2 EXOC4	2.07e-03	702	141	10	C0009402
Disease	waist-hip ratio	COL5A1 NPR3 COL11A1 CEP192 WNK1 ADCY3 ADCY8 PPP2R3A IGF1R UBN1 CIITA RNF146 OLFM2 PLCE1	2.27e-03	1226	141	14	EFO_0004343
Disease	superior parietal cortex volume measurement	GALNT1 UGCG	2.29e-03	15	141	2	EFO_0010330
Disease	Antithrombotic agent use measurement	TDRD15 BCAR1 AOPEP	2.34e-03	55	141	3	EFO_0009925
Disease	ocular sarcoidosis	MAGI1 GGT2P IGF1R USP32	2.37e-03	116	141	4	EFO_0010723
Disease	alcohol use disorder (implicated_via_orthology)	UNC13B RYR1 CHRNB2 PRKCA UNC13C	2.51e-03	195	141	5	DOID:1574 (implicated_via_orthology)
Disease	sexual dimorphism measurement	SEMA3F NPR3 EPPK1 MAP1LC3A LRRC43 DYSF GSDMC ADCY3 ADCY8 IGF1R UBN1 AOPEP BTN1A1	2.54e-03	1106	141	13	EFO_0021796
Disease	Diabetic Angiopathies	ADCY3 ADCY8	2.60e-03	16	141	2	C0011875
Disease	Microangiopathy, Diabetic	ADCY3 ADCY8	2.60e-03	16	141	2	C0025945
Disease	preeclampsia, hypertension, pregnancy-induced	NPR3 PLCE1	2.60e-03	16	141	2	EFO_0000668, MONDO_0024664
Disease	thyroid volume	IGF1R DNAH5	2.60e-03	16	141	2	EFO_0004865
Disease	Withdrawal Symptoms	ADCY8 CHRNB2 FAAH	2.72e-03	58	141	3	C0087169
Disease	Drug Withdrawal Symptoms	ADCY8 CHRNB2 FAAH	2.72e-03	58	141	3	C0086189
Disease	Substance Withdrawal Syndrome	ADCY8 CHRNB2 FAAH	2.72e-03	58	141	3	C0038587
Disease	Alzheimer disease, brain volume measurement	ADCY8 PAK2	2.94e-03	17	141	2	EFO_0006930, MONDO_0004975
Disease	hypertrophic cardiomyopathy (is_marker_for)	MAP1LC3A IGF1R	2.94e-03	17	141	2	DOID:11984 (is_marker_for)
Disease	serum alanine aminotransferase measurement	ANPEP MAP1LC3A LRRC43 NLRP3 ATP10D TENM4 MARK4 CHEK2 PRKCA PLCE1 BRWD1	3.11e-03	869	141	11	EFO_0004735
Disease	ischemia (biomarker_via_orthology)	MAP1LC3A PRKCA	3.30e-03	18	141	2	DOID:326 (biomarker_via_orthology)
Disease	asthma	MAGI1 GSAP RFC1 DYSF CSMD3 TIAM2 USP32 TRPM8 UNC13C OSTF1	3.35e-03	751	141	10	MONDO_0004979
Disease	Astigmatism	MAGI1 EIF3E TENM2 DNAH5	3.47e-03	129	141	4	HP_0000483
Disease	platelet component distribution width	SPTA1 HLF OSER1 WNK1 TXK IGF1R MARK4 CHEK2 PAK2 BRWD1	3.48e-03	755	141	10	EFO_0007984
Disease	diffuse plaque measurement	ANO4 COL5A1 CD109 CUL7 CSMD3 RRAGC METTL6 TENM4 ANXA10 AIPL1	3.57e-03	758	141	10	EFO_0010699
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	ZFC3H1 DYSF IGF1R AOPEP	3.66e-03	131	141	4	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	ZFC3H1 DYSF IGF1R AOPEP	3.66e-03	131	141	4	C4552091
Disease	Juvenile arthritis	ZFC3H1 DYSF IGF1R AOPEP	3.66e-03	131	141	4	C3495559
Disease	Juvenile psoriatic arthritis	ZFC3H1 DYSF IGF1R AOPEP	3.66e-03	131	141	4	C3714758
Disease	Juvenile-Onset Still Disease	ZFC3H1 DYSF IGF1R AOPEP	4.08e-03	135	141	4	C0087031
Disease	Nonorganic psychosis	TENM4 PRKCA APOBEC3C	4.45e-03	69	141	3	C0349204
Disease	waist circumference	HLF CWC22 ADCY3 ADCY8 PPP2R3A UNC13C DNAH5	4.67e-03	429	141	7	EFO_0004342

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLDYEAGDVSFYNMR	BTN2A3P	421	Q96KV6
EELYSQSYDAVGVMF	ADCY8	971	P40145
DYLFGKEMYQVDFLD	ACTR6	76	Q9GZN1
FDVEEFMYLVLQAAD	EOGT	496	Q5NDL2
LEDENGDMFYSQAHY	BAAT	36	Q14032
MFAYHTLGYEDLDEL	AIPL1	126	Q9NZN9
DMVDAINECYDGYFQ	ANXA10	221	Q9UJ72
FQMEEKYDYLEIEGS	CSMD3	286	Q7Z407
AGARVTIMDYEEFAY	APOBEC3B	141	Q9UH17
LDYESGDISFYNMND	BTN1A1	426	Q13410
MEDYDYVHLQGKEEF	BCAR1	661	P56945
FYFSEYMEKEDAVNI	AKAP10	391	O43572
YDQMDLAGEEEIELY	CIITA	51	P33076
VFTDVEDYMYLAKEE	ALDH1L2	811	Q3SY69
RTFQDEYEISEMVGY	GSDMC	236	Q9BYG8
GYFDEEMAVKYISEV	MASTL	126	Q96GX5
EGVAVEIMDYEDFKY	APOBEC3C	141	Q9NRW3
YFILDEFLMGGDVQD	AP1S1	111	P61966
EEGSEYYERTNMLLE	DOP1A	156	Q5JWR5
LADDLAGFYRSEYME	ANPEP	186	P15144
ERFLQEDQAMGVYLY	AOPEP	766	Q8N6M6
EEERVSYYMEGLFDE	CELSR1	276	Q9NYQ6
AYGLFDEYLEMILQF	ANO4	706	Q32M45
MEEEDLAEYFRLQYG	CCDC42	6	Q96M95
FFDAEDYYIVLELME	CHEK2	291	O96017
DYYIVLELMEGGELF	CHEK2	296	O96017
YFIQSDVDFYNEKMD	ATP10D	401	Q9P241
EDYVNMFVEGFHDAI	NPR3	351	P17342
AAIQEEMGAYGYEDL	OLFM2	161	O95897
GLDYEETAFYEMEVQ	PCDHGA7	306	Q9Y5G6
GALSMFELEYFYEEQ	PPP2R3B	406	Q9Y5P8
LDFGYLTQDMIDDYE	ZFYVE28	206	Q9HCC9
DVDYDEELYVAGNMV	ANAPC1	86	Q9H1A4
TYEMLAIEGAQAFYN	GGT3P	216	A6NGU5
EYNMDLYVLRLAEDG	MAGI1	1171	Q96QZ7
EGFVVMQSNDVDIYY	KIAA1109	281	Q2LD37
DLYMVTDLELYEAFS	DPYS	166	Q14117
MAGLLENYYEFFENE	FAM13B	201	Q9NYF5
YMESFEGIFKEQYDT	CWC22	521	Q9HCG8
NIVDDFQEYNYGTME	COL11A1	301	P12107
YDGYEISEDSFFQNM	ECE2	561	P0DPD6
IGDFGMTRDIYETDY	IGF1R	1151	P08069
EAEGAGEMLEFDYEY	MAP3K6	631	O95382
GEMLEFDYEYTETGE	MAP3K6	636	O95382
ENEDLYYEGAMPEVS	CUL7	1376	Q14999
EDMDLYSINYLHFGE	KDM4B	191	O94953
EDMDLYSINYLHFGE	KDM4E	191	B2RXH2
MYNDYYVLDDAVFVL	METTL9	301	Q9H1A3
RDAYGEFMIQVNHEY	TUBGCP6	546	Q96RT7
YDGDTFQLEYMDLEE	HLF	76	Q16534
VDGDGVLSMYELEYF	PPP2R3A	986	Q06190
FMDTGYEEVVNEYVF	METTL6	231	Q8TCB7
DSYLVGDELFVVMEY	PAK2	311	Q13177
DYFQEIGTYDAGMDI	GALNT1	301	Q10472
DYQVMDEFLYNLSSD	DNAH1	891	Q9P2D7
IQFYADESYNLMFEV	GSAP	236	A4D1B5
EGNYAIVANVESMDY	EXOC4	796	Q96A65
IDGVYDNAEYAERFM	CD109	651	Q6YHK3
LMYFVRDDSAEVDVY	KLHL21	471	Q9UJP4
YRDMDIQYHGVEADD	DUSP29	101	Q68J44
MGQLYEDNHEEDYFL	GABARAPL1	91	Q9H0R8
EVNENFEMAAAYYKE	CFAP70	646	Q5T0N1
YFLSYRMIGADVEFE	FRRS1L	121	Q9P0K9
VDSMYVFKGDEVIEY	CASQ1	126	P31415
GDVSLQEYYMDVAFL	COL6A5	2281	A8TX70
QEYYMDVAFLIDASQ	COL6A5	2286	A8TX70
IGMYDYTAQNDDELA	ITSN1	1161	Q15811
DEELYSQTYDEIGVM	ADCY3	911	O60266
QYIAEDYFMAKAIAD	UGCG	231	Q16739
YVDYADGMEEIFGSL	COL5A1	1601	P20908
VDFAMDVYKNLYSDD	EIF3E	51	P60228
MGDEVIYFRQGHEAY	BRWD1	961	Q9NSI6
YQGLYEILELAEDME	EIF4G1	1316	Q04637
NKDGYIDFMEYVAAL	GUCA1A	66	P43080
LYLVMEYASAGEVFD	MARK4	131	Q96L34
MFYDDHLEAYFEQLA	CEP192	221	Q8TEP8
YEQVMIAALDYGRDD	EMC2	56	Q15006
DEAQMEHYRGYFGDI	FAAH	516	O00519
LLFQMAESVDYDYDV	DHX40	291	Q8IX18
AEYQAYIDFEMKIGD	SART3	311	Q15020
EGDEDENMVYYFLEE	RYR1	4621	P21817
VELYDHDTYGADEFM	DYSF	1226	O75923
ESQGEMDAALHYYEL	IFT140	966	Q96RY7
EEDYELAMAELNDTY	SLC7A3	221	Q8WY07
IAESYFQEEDYEKAM	CNST	196	Q6PJW8
MFYYQDVEEAETGQL	DNAH5	81	Q8TE73
TYEMLAIEGAQAFYN	GGT2P	216	P36268
YVTYDFVKDEEGEMN	LRRC43	341	Q8N309
MAEIYRDYKDEDGFV	MAP1LC3C	101	Q9BXW4
LYFEEGDIIYITDMS	OSTF1	31	Q92882
ENVVEMYNSYLVGDE	PAK4	376	O96013
EVYFMGLIDILTQYD	PIP4K2C	366	Q8TBX8
QEFFAAMYYLLEEEK	NLRP3	526	Q96P20
ETDYIMSYFDNGEDF	POLR3GL	191	Q9BT43
DVDDGMLYEFFVKVY	TRNAU1AP	106	Q9NX07
IYVIDAQDDYMEALT	RRAGC	141	Q9HB90
ELYHEGEQVEYAEMV	WRAP53	201	Q9BUR4
EELYAGVYIDFMGTD	SEMA3F	216	Q13275
FFAENEGLDDYMEAR	TMEM151B	256	Q8IW70
FVEYFALDLLMENGE	SDHA	216	P31040
VQMEIEAAYIAFIAY	TDRD15	476	B5MCY1
MLQAGYAEYFQVELE	TDRD15	656	B5MCY1
DRLYFVMEYVNGGDL	PRKCA	411	P17252
YDMELGEEFYLDQNK	PLCE1	1641	Q9P212
DGVQDVVALMDTYYL	RFC1	1016	P35251
NETYYGRTGEFMEDF	SLC2A5	51	P22732
VDVAYRRGYFDEEMN	EPPK1	3426	P58107
YGADRFYDNIEDMIG	SLC6A12	476	P48065
AGFLYVADLENMVQY	RNF146	141	Q9NTX7
EEGMVNARFDYTYHD	TENM2	2081	Q9NT68
EIMDAAEDYAKERYG	DARS1	16	P14868
EDMAIDYESFYVYAQ	POLA2	516	Q14181
QEKDEDGFLYMVYAS	MAP1LC3A	101	Q9H492
VDDVTIEDLSGYMEY	OSER1	261	Q9NX31
IDAFYMDAYEVSNTE	SUMF1	121	Q8NBK3
DVVLYNNADGMYEVS	CHRNB2	116	P17787
YDEQVDFYGSSMEEF	ZBTB43	311	O43298
GHRYFYEMDEVEGET	ZNF451	556	Q9Y4E5
CQLELEVHYYNEMFG	VPS13A	1766	Q96RL7
VDEFAMRYGIESIYQ	UNC13C	1406	Q8NB66
NEMQKIYEDYGTVFD	TIAM2	1291	Q8IVF5
DDGLGFEYVMFYNDI	THEM4	116	Q5T1C6
NEFAGIEMTYETYER	SYCP2	1351	Q9BX26
GIENYYDDLDFKNIM	TSPAN15	131	O95858
EAMQALFVSSDYYNE	TCN1	246	P20061
YVVGKMFVDVYFQED	PHEX	416	P78562
FTEEGMVNARFDYNY	TENM4	2071	Q6N022
ADNEMGYYAEGDSLF	ROS1	1191	P08922
VDEFAMRYGIESIYQ	UNC13B	786	O14795
RYNEFLLAYEAGDML	SPTA1	1081	P02549
LDYEAGMVSFYNITD	TRIM21	411	P19474
YEMILHEFLESDYEG	VPS41	461	P49754
YGEVFADQIDLYAME	TRPM1	1011	Q7Z4N2
ISDFGMTRYVLDDEY	TXK	406	P42681
YSFGLMETNFYDQAE	TTC38	186	Q5R3I4
RIQDLIDMGYGYDES	UBN1	121	Q9NPG3
EYLNEDVNGFMEYLR	ZCCHC9	66	Q8N567
FEYVTAANYFGEIME	SRD5A1	191	P18405
EEKYDESVDVYAFGM	WNK1	396	Q9H4A3
DAEGYFLAQYLMDDF	TRPM8	231	Q7Z2W7
GVMDRGYSYDLEVEQ	PSMB5	196	P28074
DYDQGLLIFYNADDM	TRIM62	421	Q9BVG3
GIYQYDNYEEVAMDT	ZFC3H1	521	O60293
AFTSEEELGENEMYY	USP32	1241	Q8NFA0
EIDDMYTPAYGDFDF	MYORG	351	Q6NSJ0
DYFVDHMGDYEDVLA	NECAB2	121	Q7Z6G3